The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature
Apatinib is a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor-2, which has been proved to be effective and safe in treating heavily pretreated patients with gastric cancer.
| Main Authors: | , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Wolters Kluwer Health
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902403/ |